2-Chloro-3-(4-methylpiperazin-1-yl)quinoxaline, 95.0%, 10mg

(S)-2-(((Benzyloxy)carbonyl)amino)-3-(4-(tert-butoxy)phenyl)propanoic acid, 95.0%, 100g

N-(3-Methylpyridin-2-yl)acetamide, 95.0%, 25g

(S)-1-(4-Bromophenyl)ethanamine hydrochloride, 95.0%, 1g

5-methylsalicylic acid, min. 98%, for synthesis, 5 g, plastic packaging.

4-Hydroxy-3H-furan-2-one, 95.0%, 1g

4-Bromo-N-methylbutan-1-amine hydrobromide, 95.0%, 1g

2'-Amino-3'-hydroxyacetophenone>98.0%(GC)(T)1g

2-Fluoro-4-methylphenol, 98.0%, 25g

Benzeneacetamide, N-[4-[(4-chlorophenyl)methoxy]-2-pyridinyl]-2,6-difluoro-, 98%, 50mg

3-(4-Bromo-1h-pyrazol-1-yl)benzaldehyde, 95%, 250mg

3-Oxoisoindoline-5-carbonitrile, 95.0%, 1g

Nonadeca-2,4-diynoic acid, 97%, 100mg